The Phase 2 trial did show that gradual titration significantly reduces GI side effects
The program slashes the cost of the starting doses of its drugs, lowering the barrier of entry for people trying to start out on the drugs.
The REWIND (Researching Cardiovascular Events with a Weekly Incretin in Diabetes) trial assessed the effect of dulaglutide, a GLP-1RA, vs placebo added to standard of care in 9901 subjects with T2D
Studies show its essential for T-cell proliferation, natural killer cell activity, and proper inflammatory response 6
Methods Materials and chemicals RPMI, dipeptide L-alanyl-L-glutamine, glucose, HEPES, sodium bicarbonate, sodium pyruvate, and 1X Gibco Antibiotic-Antimycotic for cell culture were from Thermo Fisher Scientific (Waltham, MA)